In a move that the company hopes will expand its global presence and reach, KPS Life has confirmed its plans to establish a European headquarters with a new office in Poland.
"We are excited to announce the opening of our European headquarters in Warsaw, Poland," David Kelly, president & CEO of KPS Life, said in a press release. "This is a natural step in our global expansion strategy, which positions KPS Life to serve our existing and growing base of clients who require high quality talent as they execute against their drug development initiatives.
"The KPS Life Functional Service Provider model is a proven alternative to traditional staffing and full-service outsourcing methodologies and affords our sponsor partners the opportunity to contract dedicated, embedded resources to complement their clinical operations' teams."
The company believes that the office in Poland will be critical to global operations and cohesiveness, according to the release. KPS is already established in 45 countries and believes that the office in Poland will provide a centralized pathway to quality medical research facilities and access to talented and experienced research professionals. the release said.
"The opening of the Warsaw office signals our commitment to enhance and further grow our global presence and establish a facility in a central European location to serve our clients' needs going forward," Dr. Armand Czaplinski, general manager of European operations, said in the release. "The office will be staffed with a highly experienced recruitment team, clinical operations personnel and business development professionals. We are committed to continue to expand our global presence and capabilities in the months to come."
According to the press release, Malvern, Pennsylvania-based KPS Life "is a stand-alone functional service provider that offers global functional clinical trial outsourcing services to pharmaceutical and biotech companies of all sizes across all phases of clinical trials."
The company's services include clinical monitoring, clinical monitoring oversight, clinical trial management, data management, biometrics and medical writing, the release said.